{
  "ticker": "BIO",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02964163",
  "id": "02964163",
  "pages": 5,
  "price_sensitive": true,
  "date": "20250701",
  "time": "0844",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250701/pdf/06l9lztk3lml5y.pdf",
  "summary": "### **Material Information Summary (Biome Australia - Sales & Financial Update)**  \n\n- **Record Sales Revenue:**  \n  - FY25 unaudited sales revenue: **$18.4m** (+41% vs FY24).  \n  - Q4 FY25 revenue: **$5m** (+33% vs PCP).  \n  - June 2025 monthly revenue: **$2.1m** (+50% vs PCP).  \n\n- **Annualized Run Rate (ARR):** **$20m** (based on Q4 performance).  \n\n- **Profitability:**  \n  - Sixth consecutive quarter of **positive EBITDA** expected in Q4.  \n  - **First full-year net profit** anticipated in FY25 accounts.  \n\n- **Domestic Growth:**  \n  - Sell-through growth >50% in FY25.  \n  - Activated Probiotics now **#2 in community pharmacy probiotics revenue**.  \n\n- **Vision 27 Target:** Company on track for **$75m+ cumulative sales (FY25-27)**.  \n\n- **International Expansion:** New retailer/distributor partnerships secured (Canada, UK, Ireland, NZ), with detailed update due early July.  \n\n*No capital markets action required.*",
  "usage": {
    "prompt_tokens": 1884,
    "completion_tokens": 253,
    "total_tokens": 2137,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-30T22:49:59.552695"
}